HPMA Copolymer–Geldanamycin Conjugates
123
6. R. Mandler, C. Wu, E. A. Sausville, A. J. Roettinger, D. J. New-
man, D. K. Ho, C. R. King, D. Yang, M. E. Lippman, N. F. Lan-
dolfi, E. Dadachova, M. W. Brechbiel, and T. A. Waldmann. Im-
munoconjugates of geldanamycin and anti-HER2 monoclonal
antibodies: antiproliferative activity on human breast carcinoma
cell lines. J. Natl. Cancer Inst. 92:1573–1581 (2000).
7. Y. Kasuya, Z.-R. Lu, P. Kopecˇkova´, T. Minko, S. E. Tabibi, and
J. Kopecˇek. Synthesis and characterization of HPMA copolymer-
geldanamycin derivative conjugates. J. Control. Release 74:203–
211 (2001).
resistance in a human ovarian carcinoma cell line. J. Control.
Release 54:223–233 (1998).
20. L. W. Seymour, R. Duncan, J. Strohalm, and J. Kopecˇek. Effect
of molecular weight (Mw) of N-(2-hydroxypropyl)methacryl-
amide copolymers on body distribution and rate of excretion
after subcutaneous, intraperitoneal, and intravenous administra-
tion to rats. J. Biomed. Mater. Res. 21:1341–1358 (1987).
21. M. Dvorˇa´k, P. Kopecˇkova´, and J. Kopecˇek. High-molecular
weight HPMA copolymer-adriamycin conjugates. J. Control. Re-
lease 60:321–332 (1999).
22. J. B. Lloyd. Metabolic efflux and influx across the lysosome mem-
brane. In J. B. Lloyd and R. W. Mason (eds.), Biology of the
lysosomes. Subcellular Biochemistry. Vol. 27, Plenum Press, New
York, pp. 361–386 (1996).
23. R. Duncan, H. C. Cable, P. Rejmanova´, J. Kopecˇek, and J. B.
Lloyd. Tyrosinamide residues enhance pinocytotic capture of
N-(2-hydroxypropyl)methacrylamide copolymers. Biochim. Bio-
phys. Acta 799:1–8 (1984).
24. Y. Tabata and Y. Ikada. Effect of surface wettability of micro-
spheres on phagocytosis. J. Colloid Interface Sci. 127:132–140
(1989).
25. S. Yasukawa, H. Ohshima, N. Muramatsu, and T. Kondo. Elec-
trostatic interaction of microcapsules with guinea-pig polymor-
phonuclear leucocytes. J. Microencapsul. 7:179–184 (1990).
26. J. H. Xiu, K.-E. Magnusson, O. Stendahl, and L. Edebo. Physi-
cochemical surface properties and phagocytosis by polymorpho-
nuclear leukocytes of different serogroup of Salmonella. J. Gen.
Microbiol. 129:3075–3084 (1983).
27. J. Senior, C. Delgado, D. Fisher, C. Tilcock, and G. Gregoriadis.
Influence of surface hydrophilicity of liposomes on their interac-
tion with plasma protein and clearance from the circulation: stud-
ies with poly(ethylene glycol)-coated vesicles. Biochim. Biophys.
Acta 1062:77–82 (1991).
28. M. C. Woodle and D. D. Lasic. Sterically stabilized liposomes.
Biochim. Biophys. Acta 1113:171–199 (1992).
29. I. Schechter and A. Berger. On the active site in proteases. I.
Papain. Biochem. Biophys. Res. Commun. 27:157–162 (1967).
30. M. Baudysˇ, B. Meloun, T. Gan-Erdene, M. Fusek, M. Maresˇ, V.
Kostka, J. Pohl, and C. C. F. Blake. S-S bridges of cathepsin B
and H from bovine spleen: A basis for cathepsin B model build-
ing and possible functional implications for discrimination be-
tween exo- and endopeptidase activities among cathepsins B, H
and L. Biomed. Biochim. Acta 50:569–577 (1991).
31. O. Quraishi, D. K. Na¨gler, T. Fox, J. Sivaraman, M. Cygler, J. S.
Mort, and A. C. Storer. The occluding loop in cathepsin B defines
the pH dependence of inhibition by its propeptide. Biochemistry
38:5017–5023 (1999).
8. D. Putnam and J. Kopecˇek. Polymer conjugates with anticancer
activity. Adv. Polym. Sci. 122:55–123 (1995).
9. J. Kopecˇek, P. Kopecˇkova´, T. Minko, and Z.-R. Lu. HMPA co-
polymer-anticancer drug conjugates: design, activity, and mecha-
nism of action. Eur. J. Pharm. Biopharm. 50:61–81 (2000).
10. Y. Matsumura and H. Maeda. A new concept for macromolecu-
lar therapeutics in cancer chemotherapy: mechanism of tumori-
tropic accumulation of proteins and the antitumor agent smancs.
Cancer Res. 46:6387–6392 (1986).
11. P. Rejmanova´, J. Kopecˇek, R. Duncan, and J. B. Lloyd. Stability
in rat plasma and serum of lysosomally degradable oligopeptide
sequences in N-(2-hydroxypropyl)methacrylamide copolymers.
Biomaterials 6:45–48 (1983).
12. P. Rejmanova´, J. Pohl, M. Baudysˇ, V. Kostka, and J. Kopecˇek.
Polymers containing enzymatically degradable bonds 8. Degra-
dation of oligopeptide sequences in N-(2-hydroxypropyl)methac-
rylamide copolymers by bovine spleen cathepsin B. Makromol.
Chem. 184:2009–2020 (1983).
13. T. Minko, P. Kopecˇkova´, and J. Kopecˇek. Comparison of the
anticancer effect of free and HPMA copolymer-bound adriamy-
cin in human ovarian carcinoma cells. Pharm. Res. 16:986–996
(1999).
14. Y. Kasuya, Z.-R. Lu, P. Kopecˇkova´, and J. Kopecˇek. Improved
synthesis and evaluation of 17-substituted aminoalkylgeldanamy-
cin derivatives applicable to drug delivery systems. Bioorg. Med.
Chem. Lett. 11:2089–2091 (2001).
15. J. Kopecˇek and H. Bazˇilova´. Poly[N-(2-hydroxypropyl)methac-
rylamide] I. Radical polymerization and copolymerization. Eur.
Polym. J. 9:7–14 (1973).
16. P. Rejmanova´, J. Labsky´, and J. Kopecˇek. Aminolyses of mono-
meric and polymeric p-nitrophenyl esters of methacryloylated
amino acids. Makromol. Chem. 178:2159–2168 (1977).
ˇ
17. J. Kopecˇek, P. Rejmanova´, J. Strohalm, K. Ulbrich, B. Rı´hova´, V.
Chytry´, J. B. Lloyd, and R. Duncan. Synthetic polymeric drugs.
US Pat. 5,037,883 (1991).
18. E. Eriksson and P.-Å. Albertsson. The effect of the lipid compo-
sition on the partition of liposomes in aqueous two-phase sys-
tems. Biochim. Biophys. Acta 507:425–432 (1978).
32. D. Turk, M. Podobnik, T. Popovic, N. Katsunuma, W. Bode, R.
Huber, and V. Turk. Crystal structure of cathepsin B inhibited
with CA30 at 2.0 Å resolution: A basis for the design of specific
epoxysuccyl inhibitors. Biochemistry 34:4791–4797 (1995).
19. T. Minko, P. Kopecˇkova´, V. Pozharov, and J. Kopecˇek. HPMA
copolymer bound adriamycin overcomes MDR1 gene encoded